NET PROFIT (x1000 DKK)
EMPLOYEES
Vicore Pharma Holding AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 0 | 0 | 0 |
Financial expenses | 318 | 1,864 | 4 |
Earnings before taxes | -192,990 | -215,765 | -109,184 |
EBITDA | -192,029 | -211,755 | |
Total assets | 225,868 | 328,058 | 301,293 |
Current assets | 180,283 | 274,805 | 242,987 |
Current liabilities | 30,934 | 47,678 | 32,829 |
Equity capital | 193,175 | 278,721 | 262,751 |
- share capital | 27,347 | 26,089 | 18,593 |
Employees (average) | 21 | 16 | 13 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 85.5% | 85.0% | 87.2% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | -85.3% | -65.2% | -36.2% |
Current ratio | 582.8% | 576.4% | 740.2% |
Return on equity (ROE) | -99.9% | -77.4% | -41.6% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 5 | 3 | 5 |
Chg. No. of employees % | 31% | 23% | 63% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.